INVERNA
Live / Applied — Extension of time to oppose received (as of 10 Nov 2025)
What this means for you
Not registered yet, but its 18 Sept 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79408432
- Mark type
- Stylized text
- Filed
- 18 Sept 2024
- Published for opposition
- 14 Oct 2025
- Attorney of record
- Mark L. Weber
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products for the treatment of severe genetic diseases
- Class 042 — Scientific and technological services: Pharmaceutical research and development
Owner
- Inverna Therapeutics ApS, DK
- Argobio, FR
- Argobio, FR
Prosecution history
- 30 Mar 2026 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 29 Mar 2026 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 27 Mar 2026 — TEAS POST PUBLICATION AMENDMENT RECEIVED
- 11 Dec 2025 — CHANGE OF OWNER RECEIVED FROM IB
- 10 Nov 2025 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 14 Oct 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 14 Oct 2025 — PUBLISHED FOR OPPOSITION
- 08 Oct 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 19 Sept 2025 — REFUSAL PROCESSED BY IB
- 13 Sept 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 12 Sept 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 12 Sept 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 12 Sept 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 03 Sept 2025 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
- 03 Sept 2025 — REFUSAL PROCESSED BY MPU